Pharma Report on Pancreatic Cancer – Pipeline Review, H2 2020

Source: https://www.researchbymarkets.com/report/pancreatic-cancer-pipeline-review-h2-2020-645867.html

Pancreatic Cancer – Pipeline Review, H2 2020

Summary

Pancreatic Cancer – Pipeline Review, H2 2020, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Predisposing factors include age, gender, smoking, diabetes and family history. Treatment includes surgery, chemotherapy and radiation therapy.

Report Highlights

Pancreatic Cancer – Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Pancreatic Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pancreatic Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pancreatic Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 22, 207, 220, 2, 14, 386, 63 and 10 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical and Discovery stages comprises 27, 14, 3, 1, 67 and 11 molecules, respectively.

Pancreatic Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Pancreatic Cancer (Oncology).
– The pipeline guide reviews pipeline therapeutics for Pancreatic Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Pancreatic Cancer (Oncology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Pancreatic Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Pancreatic Cancer (Oncology)

Reasons to Buy

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Pancreatic Cancer (Oncology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Pancreatic Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies Mentioned:
4D Pharma Plc
4SC AG
A2 Biotherapeutics Inc
AB Pharma Ltd
AB Science SA
AbbVie Inc
AbClon Inc
Ability Pharmaceuticals SL
AC Bioscience SA
Accendatech Co Ltd
Accuronix Therapeutics Inc
ACF Pharmaceuticals LLC
Aclaris Therapeutics Inc
Acrotech Biopharma LLC
Actuate Therapeutics Inc
Acura Nanomedicine Inc
Adamed Sp zoo
ADC Therapeutics SA
Adlai Nortye Biopharma Co Ltd
Aduro BioTech Inc
Advanced BioDesign
Advanz Pharmaceutical Corp Ltd
Advenchen Laboratories LLC
Adze Biotechnology Inc
Affimed GmbH
Agenus Inc
Agios Pharmaceuticals Inc
AGV Discovery SAS
AIkido Pharma Inc
AIM ImmunoTech Inc
Alissa Pharma
Alkermes Plc
Alligator Bioscience AB
Allinky Biopharma SL
Almac Discovery Ltd
Alphamab Oncology
AltruBio Inc
ALX Oncology Inc
amcure GmbH
Amgen Inc
AmMax Bio Inc
Amphera BV
Amplia Therapeutics Ltd
Anavex Life Sciences Corp
Andarix Pharmaceuticals Inc
Andes Biotechnologies
ANP Technologies Inc
Antapodia Therapeutics Inc
AntiCancer Inc
Apac Biotech Pvt Ltd
APEIRON Biologics AG
Apexian Pharmaceuticals Inc
Apexigen Inc
Aphios Corp
Apollomics Inc
Aprilbio Co Ltd
Aravive Inc
Arbele Ltd
Arcus Biosciences Inc
Argonaut Therapeutics Ltd
Asana BioSciences LLC
Ascelia Pharma AB
Ascenta Therapeutics Inc
Ascentage Pharma Group International
Ascentawits Pharmaceuticals Ltd
Asclepiumm Taiwan Co Ltd
Asclepius Technology Company Group Suzhou Co Ltd
Astellas Pharma Inc
AstraZeneca Plc
Augustus BioTarget Inc
AUM Biosciences Pte Ltd
Aurigene Discovery Technologies Ltd
Avenzoar Pharmaceuticals Inc
AVEO Pharmaceuticals Inc
Avican Inc
Avicenna Therapeutics Inc
Azure Health Technology Ltd
Basilea Pharmaceutica Ltd
Bausch Health Companies Inc
Bavarian Nordic A/S
Bayer AG
BeiGene Ltd
Beijing Syngentech Co Ltd
Bellicum Pharmaceuticals Inc
Benhealth Biopharmaceutical (Shenzhen) Co Ltd
Berg LLC
BerGenBio ASA
Bessor Pharma LLC
Betta Pharmaceuticals Co Ltd
Bexion Pharmaceuticals LLC
BeyondBio Inc
BeyondSpring Inc
Bicycle Therapeutics Plc
Bio-Path Holdings Inc
BioAtla LLC
Biocon Ltd
Biokine Therapeutics Ltd
BioLineRx Ltd
BioMed Valley Discoveries Inc
BioMoti Ltd
Biomunex Pharmaceuticals
BioNTech SE
BioTheryX Inc
BioXcel Therapeutics Inc
BJ Bioscience Inc
BLR Bio LLC
Boehringer Ingelheim International GmbH
Bold Therapeutics Inc
Bolt Biotherapeutics Inc
BriaCell Therapeutics Corp
BrightGene Bio-Medical Technology Co Ltd
Bristol-Myers Squibb Co
Calidi Biotherapeutics Inc
Cancer Advances Inc
Cancer Prevention Pharmaceuticals Inc
Cancer Vaccines Ltd
Candel Therapeutics
Canget BioTekpharma LLC
Cannabis Science Inc
Cantargia AB
Cantex Pharmaceuticals Inc
Cardiff Oncology Inc
CARsgen Therapeutics Ltd
Cascade Prodrug Inc
Cassiopea SpA
CCRP Therapeutics GmbH
Celldex Therapeutics Inc
Celleron Therapeutics Ltd
CellionBioMed Inc
Cellivery Therapeutics Inc
Cello Therapeutics Inc
Celprogen Inc
Celyad Oncology
Cend Therapeutics Inc
Centrose LLC
CheMedImmune Inc
ChemoCentryx Inc
ChemRegen Inc
Chengdu Jinrui Foundation Biotechnology Co Ltd
Chimeric Therapeutics Ltd
Chiome Bioscience Inc
CHO Pharma Inc
Cloaked Therapeutics LLC
Clovis Oncology Inc
CLS Therapeutics
CNS Pharmaceuticals Inc
COARE Biotechnology Inc
COARE Holdings Inc
Codiak BioSciences Inc
Coherent Biopharma
Convalife
Convert Pharmaceuticals SA
Corcept Therapeutics Inc
Corvus Pharmaceuticals Inc
Cotinga Pharmaceuticals Inc
Counterpoint Biomedica LLC
CPL Biologicals Pvt Ltd
CrystalGenomics Inc
CSPC Pharmaceutical Group Ltd
CStone Pharmaceuticals Co Ltd
Cumberland Pharmaceuticals Inc
Curegenix Inc
CureLab Oncology Inc
CureMeta LLC
Cyclacel Pharmaceuticals Inc
Cyteir Therapeutics Inc
CytImmune Sciences Inc
Cytocom Inc
Cytodyn Inc
Cytonus Therapeutics Inc
CytoTools AG
Cytovia Inc
CyTuVax BV
DAE HWA Pharmaceutical Co Ltd
Daiichi Sankyo Co Ltd
Decoy Biosystems Inc
DEKK-TEC Inc
Delta-Fly Pharma Inc
DeMelle OncoPharma LLC
DevaCell Inc
Diakonos Research Ltd
Diazon Pharmaceuticals Inc
Diffusion Pharmaceuticals Inc
Diverse Biotech Inc
Domain Therapeutics SA
DwarfBody-Therapeutics Operating Co BV
eFFECTOR Therapeutics Inc
Eisai Co Ltd
Eleison Pharmaceuticals LLC
Eli Lilly and Co
Elicio Therapeutics
Elthera AG
ENB Therapeutics LLC
EnGeneIC Ltd
Engitix Ltd
Enochian Biosciences Inc
Epeius Biotechnologies Corp
Epidestiny Inc
Epigene Therapeutics Inc
Ergon Pharmaceuticals LLC
ERYTECH Pharma SA
Esanex Inc
Escend Pharmaceuticals Inc
Esperance Pharmaceuticals Inc
Esperas Pharma Inc
Essential Biotechnology LLC
Eucure (Beijing) Biopharma Co Ltd
Eureka Therapeutics Inc
Eutilex Co Ltd
Everfront Biotech Inc
Evestra Inc
Exelixis Inc
EXUMA Biotech Inc
F. Hoffmann-La Roche Ltd
Faron Pharmaceuticals Oy
Fate Therapeutics Inc
Felicitex Therapeutics Inc
FibroGen Inc
Flag Therapeutics Inc
Flavocure Biotech LLC
Formosa Pharmaceuticals Inc
Fujifilm Holdings Corp
Galera Therapeutics Inc
GamaMabs Pharma SA
Gbiologics Inc
GC Pharma
GEEN Biotechnology Inc
Geistlich Pharma AG
GEMoaB Monoclonals GmbH
GeneCare Research Institute Co Ltd
Geneius Biotechnology Inc
Genelux Corp
Genemedicine Ltd
Genentech USA Inc
Geneos Therapeutics Inc
GeneScience Pharmaceuticals Co Ltd
Genexine Inc
Genisphere LLC
Genmab AS
Genomefrontier Therapeutics Inc
Genoscience Pharma
GeoVax Labs Inc
Gilead Sciences Inc
GlaxoSmithKline Plc
GlycoMimetics Inc
GlycoNex Inc
GO Therapeutics Inc
Golden Biotechnology Corp
Gossamer Bio Inc
Gracell Biotechnology Ltd
Gradalis Inc
Gritstone Oncology Inc
Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangzhou Sinogen Pharmaceutical Co Ltd
H2Biologics Inc
HaimBio Ltd
Hangzhou DAC Biotech Co Ltd
Hangzhou Neoantigen Therapeutics Co Ltd
Hanmi Pharmaceuticals Co Ltd
Harbin Gloria Pharmaceuticals Co Ltd
Harpoon Therapeutics Inc
Hebei Senlang Biotechnology Inc Ltd
HEC Pharm Co Ltd
Heidelberg Pharma AG
Helix BioPharma Corp
Helixmith Co Ltd
Hibercell Inc
Hope Biosciences Inc
Hope Biosciences LLC
Huabo Biopharm Co Ltd
Hummingbird Bioscience Pte Ltd
Hyundai Bioscience Co., Ltd.
i2 Pharmaceuticals Inc
iCELL Biotechnology Co Ltd
Icell Kealex Therapeutics LLC
Ideaya Biosciences Inc
Idera Pharmaceuticals Inc
ImCheck Therapeutics SAS
Immix BioPharma Inc
Immodulon Therapeutics Ltd
Immune System Key Ltd
Immunitor Inc
ImmunityBio Inc
Immunogenesis Inc
Immunomedics Inc
ImmunoRestoration Inc
Immunos Therapeutics AG
Immunotope Inc
Immunovo BV
ImmunSYS Inc
Immupharma Plc
Imugene Ltd
Incanthera Ltd
Incyte Corp
Inflection Biosciences Ltd
Innate Pharma SA
InnoMab Pte Ltd
Innopharmax Inc
Innovation Pharmaceuticals Inc
Innovative Cellular Therapeutics Co Ltd
Inovio Pharmaceuticals Inc
Intensity Therapeutics Inc
InteRNA Technologies BV
Intrepida Bio Inc
Inventiva
InvivoGen Therapeutics
InxMed Shanghai Co Ltd
IO Biosciences Inc
Io Therapeutics Inc
Ionic Pharmaceuticals LLC
Ionova Life Science Co Ltd
Iovance Biotherapeutics Inc
Ipsen SA
ISU ABXIS Co Ltd
January Therapeutics Inc
JenKem Technology Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Jivana Biotechnology Inc
Johnson & Johnson
Kalos Therapeutics Inc
Kalyra Pharmaceuticals Inc
Kangen Pharmaceuticals Co Ltd
Kanyr Pharma Inc
Karyopharm Therapeutics Inc
Kazia Therapeutics Ltd
Keystone Nano Inc
Kitov Pharma Ltd
KLUS Pharma Inc
Komipharm International Co Ltd
Kringle Pharma Inc
Kupffer Biotherapeutics Inc
Kymab Ltd
Kyowa Kirin Co Ltd
L.E.A.F. Pharmaceuticals LLC
LA Cell Inc
Lantern Pharma Inc
Le Sun Pharmaceuticals Ltd
Lead Discovery Center GmbH
Legend Biotech Corp
Leucid Bio Ltd
LIfT BioSciences Ltd
Liminal BioSciences Inc
Linnaeus Therapeutics Inc
Lipomedics Ltd
LipoSeuticals Inc
Lixte Biotechnology Holdings Inc
Lodo Therapeutics Corp
Loki Therapeutics Inc
Lokon Pharma AB
Loxo Oncology Inc
Luminus Biosciences Inc
Lumobiotics GmbH
Lumosa Therapeutics Co Ltd
Luye Pharma Group Ltd
Lykera biomed SA
MabVax Therapeutics Holdings Inc
Machavert Pharmaceuticals LLC
MacroGenics Inc
Marino Biotechnology Co Ltd
Marker Therapeutics Inc
Max Biopharma Inc
MaxiVAX SA
Meabco AS
MediaPharma SRL
Medical Guidance Systems LLC
Medicenna Therapeutics Corp
MediciNova Inc
Medicon Pharmaceuticals Inc
MedPacto Inc
Mekanistic Therapeutics LLC
Merck & Co Inc
Merck KGaA
Mereo Biopharma Group Plc
Merus NV
MetiMedi Pharmaceuticals Co Ltd
Metis Precision Medicine
Metromedia Bio-Science LLC
Migra-Therapeutics LLC
Millennium Pharmaceuticals Inc
Mina Therapeutics Ltd
Minneamrita Therapeutics LLC
Mirati Therapeutics Inc
Moderna Inc
Modulus Oncology Ltd
Molecular Partners AG
Molecular Targeting Technologies Inc
Molecular Templates Inc
Moleculin Biotech Inc
Momotaro-Gene Inc
Monopar Therapeutics Inc
Mundipharma EDO GmbH
Mustang Bio Inc
Mycenax Biotech Inc
Nanjing Bioheng Biotech Co Ltd
Nanjing Iaso Biotherapeutics Co Ltd
NanoCarrier Co Ltd
Nanogenics Ltd
Nanology LLC
NanoPharmaceuticals LLC
NantBioScience Inc
NantKwest Inc
Nascent Biotech Inc
Navire Pharma Inc
Nektar Therapeutics
NeoTX Therapeutics Ltd
New B Innovation Ltd
NGM Biopharmaceuticals Inc
Nitto BioPharma Inc
NMS Group SpA
NomoCan Pharmaceuticals LLC
Northern Biologics Inc
Northwest Biotherapeutics Inc
NovalGen Ltd
NovaRock Biotherapeutics Inc
Novartis AG
Novita Pharmaceuticals Inc
Novonco Pharmaceuticals Inc
NOX Pharmaceuticals Inc
Noxxon Pharma AG
OBI Pharma Inc
Oceanyx Pharmaceuticals Inc
Omeros Corp
OncBioMune Pharmaceuticals Inc
Oncoceutics Inc
Oncocross Co Ltd
Oncodesign SA
Oncology Research International Ltd
Oncology Venture A/S
Oncolys BioPharma Inc
Oncolytics Biotech Inc
Oncomatryx Biopharma SL
OncoOne Research & Development GmbH
OncoQuest Inc
OncoSec Medical Inc
OncoTAb Inc
Oncotelic Inc
OncoTherapy Science Inc
OncoTherics Ltd
OncoTrap Inc
Oncovir Inc
OncXerna Therapeutics Inc
Oneness Biotech Co Ltd
Ono Pharmaceutical Co Ltd
Opsona Therapeutics Ltd
Optimum Therapeutics LLC
Orano Med LLC
Oregon Therapeutics
Orgenesis Inc
Oribase Pharma
ORIC Pharmaceuticals Inc
Oryx GmbH & Co KG
OSE Immunotherapeutics
Oxford BioTherapeutics Ltd
Palisades Therapeutics
PanTher Therapeutics Inc
Patrys Ltd
Peptron Inc
PersonGen Biomedicine Suzhou Co Ltd
Pfizer Inc
Phanes Therapeutics Inc
Pharma Mar SA
PharmAbcine Inc
PharmaCyte Biotech Inc
Pharmaxis Ltd
Phenex Pharmaceuticals AG
pHion Therapeutics Ltd
Phoenix Biotechnology Inc
Phoenix Life Sciences International Ltd
Phosplatin Therapeutics LLC
Pieris Pharmaceuticals Inc
Placon Therapeutics Inc
Plexxikon Inc
Plus Therapeutics Inc
PNB Vesper Life Science Pvt Ltd
POP Biotechnologies Inc
Poseida Therapeutics Inc
Precision Biologics Inc
Prescient Therapeutics Ltd
Prestige BioPharma Pte Ltd
PRISM Pharma Co Ltd
Processa Pharmaceuticals Inc
ProDa BioTech LLC
Propanc Biopharma Inc
Protheragen Inc
Provectus Biopharmaceuticals Inc
Psivac Ltd
Puma Biotechnology Inc
Purdue Pharma LP
Puretech Health Plc
Qu Biologics Inc
Quadriga BioSciences Inc
Qualigen Therapeutics Inc
Quest PharmaTech Inc
Quimatryx SL
Qurgen Inc
RadImmune Therapeutics Inc
Rafael Pharmaceuticals Inc
Redbiotec AG
RedHill Biopharma Ltd
Redx Pharma Plc
Regeneron Pharmaceuticals Inc
RemeGen Ltd
Resarci Therapeutics LLC
Resonant Therapeutics Inc
Reven Pharmaceuticals Inc
Revolution Medicines Inc
Rexahn Pharmaceuticals Inc
Rgenix Inc
Rhizen Pharmaceuticals SA
Rigenerand Srl
Rimo Therapeutics Inc
Riptide Bioscience Inc
Rise Biopharmaceutical Ltd
RS Research
Sagetis Biotech SL
Sagimet Biosciences
Samumed LLC
Samyang Holdings Corp
Sanofi
Sapphire Biotech Inc
Sareum Holdings Plc
SATT Nord
Savoy Pharmaceuticals Inc
Scancell Holdings Plc
Scandion Oncology AS
ScarTec Therapeutics BV
Schrodinger LLC
Seattle Genetics Inc
SEEKYO Therapeutics
Segue Therapeutics LLC
SELLAS Life Sciences Group Inc
Senhwa Biosciences Inc
Senti Biosciences Inc
SevenGenes Inc
Shanghai Biomed-Union Biotechnology Co Ltd
Shanghai Bioray Laboratory Inc
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Shanghai GeneChem Co Ltd
Shanghai Haihe Biopharma Co Ltd
Shanghai Huilun Life Science&Technology Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Shenzhen BinDeBio Ltd
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Shijiazhuang Yiling Pharmaceutical Co Ltd
Siamab Therapeutics Inc
Sichuan Kelun Pharmaceutical Co Ltd
Signablok Inc
SignalChem Lifesciences Corp
SignalRx Pharmaceuticals Inc
SilaGene Inc
Silenseed Ltd
Sillajen Biotherapeutics
Singh Biotechnology LLC
Sino Biopharmaceutical Ltd
Sinocelltech Ltd
siRNAgen Therapeutics Corp
Sirnaomics Inc
SN BioScience
Soluventis GmbH
Sonoval LLC
Soricimed Biopharma Inc
Sorrento Therapeutics Inc
Speratum
Spring Bank Pharmaceuticals Inc
SpringWorks Therapeutics Inc
Starpharma Holdings Ltd
Stcube Inc
Stemirna Therapeutics Inc
Sublime Therapeutics
Sumitomo Dainippon Pharma Oncology, Inc
Sun BioPharma Inc
Suzhou Sinovent Pharmaceuticals Co Ltd
SynCore Biotechnology Co Ltd
Syndivia SAS
SynerGene Therapeutics Inc
Synovo GmbH
SyntheX Inc
Syntrix Biosystems Inc
T-Cure Bioscience Inc
TAE Life Sciences LLC
Taiho Oncology Inc
Taiho Pharmaceutical Co Ltd
Takara Bio Inc
Takeda Pharmaceutical Co Ltd
Takis Srl
TargaGenix Inc
Targovax ASA
Tarveda Therapeutics Inc
Telesis Therapeutics LLC
Telix Pharmaceuticals Ltd
tella Inc
Tempest Therapeutics Inc
TenCure Ltd
Tessa Therapeutics Ltd
TEZCAT Laboratories
TGV Laboratories Inc
The National Institute for Biotechnology in the Negev Ltd
TherapyX Inc
Tianjin Hengjia Biotechnology Development Co Ltd
Tiziana Life Sciences Plc
Tmunity Therapeutics Inc
Tonix Pharmaceuticals Holding Corp
TOT Biopharm Co Ltd
Transcenta Holding Ltd
Transcode√ā¬†Therapeutics Inc
Transcriptogen Ltd
Transgene SA
Transtarget Inc
Treadwell Therapeutics Inc
Trio Medicines Ltd
TriSalus Life Sciences Inc
Trishula Therapeutics Inc
TVAX Biomedical Inc
Twoxar Inc
Tyg Oncology Ltd
Tyme Technologies Inc
UbiVac LLC
Vaccinex Inc
ValiRx Plc
Valiseek Ltd
Vanquish Oncology Inc
VasGene Therapeutics Inc
Vault Pharma Inc
Vaximm AG
VCN Biosciences SL
Vect-Horus SAS
Venus Remedies Ltd
Verastem Inc
Vertex Pharmaceuticals Inc
Veru Inc
Vicus Therapeutics LLC
Vigeo Therapeutics Inc
Viral Gene Inc
Viralytics Pty Ltd
Virobay Inc
ViroStatics SRL
Vivacitas Oncology Inc
VM Discovery Inc
Voronoi Group
Westwood Bioscience Inc
Wntrix Inc
Worphmed Srl
WuXi AppTec Co Ltd
Xencor Inc
XTuit Pharmaceuticals Inc
XuanZhu Pharma Co Ltd
Y-Biologics Inc
Yisheng Biopharma Co Ltd
Zelira Therapeutics Ltd
Zelluna Immunotherapy AS
Zhejiang Teruisi Pharmaceutical Inc
Zhejiang Yangshengtang Biotech Co Ltd
Zhengda Tianqing Kangfang Shanghai Biomedical Technology Co Ltd
Zonula Inc
Zovis Pharmaceuticals
Zucero Therapeutics Ltd


For queries regarding this report: https://www.researchbymarkets.com/sample-request/645867

Contact Us:
ResearchByMarkets.com
Ritesh Tiwari, Director
enquiry@researchbymarkets.com
USA: +1-800-416-3124
https://www.researchbymarkets.com
https://www.researchbymarkets.com/aboutus

Follow us on Social Media:
Facebook: https://www.facebook.com/researchbymarkets/
LinkedIn: https://www.linkedin.com/company/researchmarkets
Twitter: https://twitter.com/ResearchByMrkts

Ritesh Tiwari is the Founder of Research By Markets. He has more than 7 years experience in the Market Research industry and a total experience spanning 18+ years. His core experience is in Sales and International Recruitments. Ritesh is a big foodie and a huge football fan, supporting Manchester United (EPL) and FC Barcelona (La Liga). He hardly misses watching any matches when these teams are playing. Get in touch with Ritesh via: enquiry@researchbymarkets.com *Industry Press Release is a part of Research By Markets.